One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

Basit Öğe Kaydı
dc.contributor.authorUytun, S.
dc.contributor.authorPolat, S. Eryilmaz
dc.contributor.authorTabakci, S. Ozkan
dc.contributor.authorCinel, G.
dc.contributor.authorEmiralioglu, N.
dc.contributor.authorYalcin, E.
dc.contributor.authorKiper, N.
dc.date.accessioned2024-02-23T14:27:14Z
dc.date.available2024-02-23T14:27:14Z
dc.date.issued2022
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.doi10.1183/13993003.congress-2022.2642
dc.identifier.issn0903-1936
dc.identifier.issn1399-3003
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2022.2642
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14512
dc.identifier.volume60en_US
dc.identifier.wosWOS:000893392403484en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.ispartofEuropean Respiratory Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleOne-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu